Publication | Closed Access

Carboplatin and pemetrexed with or without pembrolizumab for advanced, non-squamous non-small-cell lung cancer: a randomised, phase 2 cohort of the open-label KEYNOTE-021 study

OncologyMetronomic TherapyPathologyBronchial NeoplasmOpen-label Keynote-021 StudyCancer TreatmentPhase 2MedicineRadiation OncologyLung Cancer